1. Home
  2. SSTK vs CTMX Comparison

SSTK vs CTMX Comparison

Compare SSTK & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shutterstock Inc.

SSTK

Shutterstock Inc.

HOLD

Current Price

$18.77

Market Cap

675.2M

Sector

Technology

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.12

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSTK
CTMX
Founded
2003
2008
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
675.2M
596.2M
IPO Year
2012
2015

Fundamental Metrics

Financial Performance
Metric
SSTK
CTMX
Price
$18.77
$4.12
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$25.00
$6.50
AVG Volume (30 Days)
218.9K
2.1M
Earning Date
11-05-2025
11-06-2025
Dividend Yield
7.03%
N/A
EPS Growth
66.87
50.22
EPS
1.69
0.24
Revenue
$1,020,010,000.00
$113,631,000.00
Revenue This Year
$11.41
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$11.14
$17.49
Revenue Growth
13.06
N/A
52 Week Low
$14.35
$0.40
52 Week High
$38.80
$4.62

Technical Indicators

Market Signals
Indicator
SSTK
CTMX
Relative Strength Index (RSI) 38.63 56.75
Support Level $17.92 $3.78
Resistance Level $19.58 $4.20
Average True Range (ATR) 0.79 0.23
MACD -0.01 -0.01
Stochastic Oscillator 23.40 72.39

Price Performance

Historical Comparison
SSTK
CTMX

About SSTK Shutterstock Inc.

Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market, but also has its presence in Europe and Rest of the Countries.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: